XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of segment performance The following is a summary of segment performance:
(in thousands)For the Three Months Ended March 31,
CAGWaterLPDOtherConsolidated Total
2023
Revenue$827,279 $38,883 $29,208 $4,825 $900,195 
Income from operations$261,750 $16,971 $1,308 $370 $280,399 
Interest expense, net(12,711)
Income before provision for income taxes267,688 
Provision for income taxes53,634 
Net income attributable to IDEXX Laboratories, Inc. stockholders$214,054 
2022
Revenue$761,184 $36,371 $30,870 $8,124 $836,549 
Income from operations$223,125 $16,654 $6,737 $1,828 $248,344 
Interest expense, net(6,853)
Income before provision for income taxes241,491 
Provision for income taxes47,526 
Net income attributable to IDEXX Laboratories, Inc. stockholders$193,965